PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.097 AUD
-7.62%
Market Closed
Updated:
May 16, 2024
PYC Therapeutics Ltd
Cash from Financing Activities
|
PYC Therapeutics Ltd
Cash from Financing Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Cash from Financing Activities
AU$28.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
22%
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Financing Activities
AU$76m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Financing Activities
$67.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Financing Activities
-AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Financing Activities
AU$10.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
28.8m
AUD
28.8m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Cash from Financing Activities amounts to 28.8m AUD.
What is PYC Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
22%
22%
The average annual Cash from Financing Activities growth rates for PYC Therapeutics Ltd have been -9% over the past three years , 27% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
